The European Fine Chemicals Group (EFCG), a sector group of Cefic representing the European manufacturers of fine chemicals including Active Pharmaceutical Ingredients (APIs), drug substances, excipients and intermediates, supports a strong Biotech Act I that strengthens the competitiveness of European biotech and biomanufacturing sectors, which are essential for EU health security and strategic autonomy.

The members of EFCG call for a policy approach that reflects the complexity of the health biotechnology value chain and anchors key manufacturing steps in Europe. This approach should address all strategic elements of the health biomanufacturing value chain, ensure access to key biomanufacturing inputs, deliver consistency across legislation, and provide fit-for-purpose financing and funding for scale-up and modernisation—ultimately strengthening competitiveness and EU health security.